You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bromocriptine

Showing 1 - 25 of 69
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia, Glucose Intolerance Trial in Pittsburgh (Bromocriptine)

Not yet recruiting
  • Schizophrenia
  • Glucose Intolerance
  • Bromocriptine
  • Pittsburgh, Pennsylvania
    VA Pittsburgh Healthcare System
Oct 11, 2022

Overweight and Obesity, Eating Behavior Trial in Chapel Hill (Placebo, Bromocriptine-QR)

Completed
Has Results
  • Overweight and Obesity
  • Eating Behavior
  • Chapel Hill, North Carolina
    University of North Carolina, Chapel Hill
Aug 12, 2022

Peripartum Cardiomyopathy, Postpartum Trial in Pittsburgh (Bromocriptine, Placebo, Guideline Directed Medical Therapy for Heart

Recruiting
  • Peripartum Cardiomyopathy, Postpartum
  • Bromocriptine
  • +4 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jun 9, 2022

Diabetic Autonomic Neuropathy Trial in Norfolk (Cycloset, Placebo)

Completed
Has Results
  • Diabetic Autonomic Neuropathy
  • Norfolk, Virginia
    Eastern Virgnia Medical School, Strelitz Diabetes Center
Nov 12, 2021

Type 1 Diabetes Trial in Aurora (Bromocriptine, Placebo)

Completed
Has Results
  • Type 1 Diabetes
  • Bromocriptine
  • Placebo
  • Aurora, Colorado
    University of Colorado-Denver, Anshutz Medical Campus
Aug 16, 2021

Obesity Trial in Cologne, Luebeck, Tübingen (Bromocriptine, Placebo)

Recruiting
  • Obesity
  • Bromocriptine
  • Placebo
  • Cologne, Germany
  • +2 more
May 31, 2022

Familial Alzheimer (FAD), PSEN1 Mutation Trial in Japan (Bromocriptine, Placebos)

Completed
  • Familial Alzheimer Disease (FAD)
  • PSEN1 Mutation
  • Bromocriptine
  • Placebos
  • Nagoya, Aichi, Japan
  • +7 more
Mar 29, 2022

Subarachnoid Hemorrhage, Subdural Hematoma, Traumatic Brain Injury Trial in San Francisco (Bromocriptine 5 MG, Acetaminophen 650

Completed
Has Results
  • Subarachnoid Hemorrhage
  • +5 more
  • Bromocriptine 5 MG
  • Acetaminophen 650 MG
  • San Francisco, California
  • +1 more
Jun 22, 2021

Addiction Trial in Berkeley, San Francisco (Tolcapone, Placebo, Bromocriptine)

Withdrawn
  • Addiction
  • Berkeley, California
  • +1 more
Nov 12, 2021

Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread Trial in Zürich (Low dose naltrexone, Placebo, Bromocriptine Mesylate

Recruiting
  • Fibromyalgia
  • +2 more
  • Low dose naltrexone
  • +3 more
  • Zürich, Switzerland
    Balgrist Campus
Feb 20, 2022

Anorexia Nervosa Trial in San Diego (amisulpride, bromocriptine)

Recruiting
  • Anorexia Nervosa
  • San Diego, California
    University of California San Diego
Sep 2, 2021

Peripartum Cardiomyopathy Trial in Hannover (Bromocriptine)

Completed
  • Peripartum Cardiomyopathy
  • Bromocriptine
  • Hannover, Niedersachsen, Germany
    Hannover Medical School (MHH)
Sep 2, 2020

Identify Specific Predictors of Spatial Neglect Recovery

Active, not recruiting
  • Spatial Neglect
  • +5 more
    • Chester, New Jersey
    • +2 more
    Feb 16, 2021

    Diabetes, Type 2 Trial in Dallas (QR-bromocriptine)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Dallas, Texas
    • +1 more
    Sep 13, 2019

    Ovarian Hyperstimulation Syndrome Trial in Cairo (Fludrocortisone 0.1 Milligrams (mg), Bromocriptine)

    Completed
    • Ovarian Hyperstimulation Syndrome
    • Fludrocortisone 0.1 Milligrams (mg)
    • Bromocriptine
    • Cairo, Maadi, Egypt
      Ganin Fertility Center
    Apr 16, 2020

    Healthy Trial in Toronto (Olanzapine 10 milligram, Bromocriptine 5 milligram, Placebo oral tablet)

    Unknown status
    • Healthy
    • Olanzapine 10 milligram
    • +2 more
    • Toronto, Ontario, Canada
      Toronto General Hospital
    Dec 2, 2019

    Diabetic Macular Edema Trial (Bromocriptine 2.5 MG, Metoprolol 25 MG, Tamsulosin 0.4 MG)

    Withdrawn
    • Diabetic Macular Edema
    • Bromocriptine 2.5 MG
    • +3 more
    • (no location specified)
    Mar 28, 2019

    Type 2 Diabetes Trial in San Antonio (Cycloset)

    Completed
    Has Results
    • Type 2 Diabetes
    • San Antonio, Texas
      University of Texas Health Science Center
    Jun 20, 2019

    Lactation Suppressed Trial in Warsaw (Bromocriptine, Cabergoline, Natural methods)

    Unknown status
    • Lactation Suppressed
    • Bromocriptine
    • +2 more
    • Warsaw, Poland
      Żelazna Medical Centre
    Jul 26, 2019

    Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)

    Active, not recruiting
    • Lactation Suppressed
    • Cabergoline 1 MG
    • Placebo
    • Stanford, California
      Stanford University
    Jul 7, 2022

    Parkinson Disease Trial in France (Surgery under general anesthesia with experimental targeting, Usual Surgery)

    Recruiting
    • Parkinson Disease
    • Surgery under general anesthesia with experimental targeting
    • Usual Surgery
    • Amiens, France
    • +9 more
    May 31, 2022

    Parkinson Disease Trial in Porto Alegre (Leap Motion Controller on flat display)

    Not yet recruiting
    • Parkinson Disease
    • Leap Motion Controller on flat display
    • Porto Alegre, RS, Brazil
      Universidade Federal de Ciências da Saúde de Porto Alegre
    Jun 18, 2023

    Adenomyosis Trial in Rochester (Vaginal Bromocriptine)

    Completed
    • Adenomyosis
    • Vaginal Bromocriptine
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 10, 2018

    Parkinson Disease Trial in Porto Alegre (Leap Motion Controller on flat display, Leap Motion Controller in Head-Mounted Display)

    Recruiting
    • Parkinson Disease
    • Leap Motion Controller on flat display
    • Leap Motion Controller in Head-Mounted Display
    • Porto Alegre, RS, Brazil
      Universidade Federal de Ciências da Saúde de Porto Alegre
    Jan 7, 2023

    Peripartum Cardiomyopathy Trial in Monteal (Bromocriptine, Guideline-driven medical therapy (GDMT))

    Recruiting
    • Peripartum Cardiomyopathy
    • Bromocriptine
    • Guideline-driven medical therapy (GDMT)
    • Monteal, Quebec, Canada
      Montreal Heart Institute
    Sep 2, 2017